The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects
Clinical trial NCT05085197 · COMPLETED
Trial details
- NCT number
- NCT05085197
- Sponsor
- Staidson Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2022-04-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.